By Santiago Remón; Reviewer, Franco M. López, Fundacion BASES Introduction We have long understood health as a basic human need. The pharmaceutical industry, that business sector dedicated to the manufacture, preparation and marketing of medicinal chemicals for the treatment and prevention of diseases, has played a very important role in health care for […]
Author: publisher
TES Report: Hydroxychloroquine & The Burden of Proof
The Economic Standard is proud to present our first white paper. We demonstrate through meticulously sourced analysis: 1) Hydroxychloroquine (HCQ) is a safe, versatile medicine that has treated hundreds of millions of people for many diseases over seven decades. 2) Numerous controlled observational studies and meta-analyses have demonstrated that HCQ can help […]
Problematic RCTs of hydroxychloroquine vs. COVID-19
By Erik Sass, TES Editor-in-Chief Following is a compilation of randomized controlled trials (and other types of studies) of hydroxychloroquine as a treatment for COVID-19, listing the flaws and errors which invalidate their conclusions. To add a trial entry or send corrections, please email TES Editor-in-Chief Erik Sass: eriksass@gmail.com . Boulware, et al. […]
The Assault On Early COVID-19 Treatment: Congressional Hearing Speaks Volumes about Our Failed Pandemic Response
By Donald Pompan, MD, and Michael M. Jacobs, MD, MPH The Senate Homeland Security Committee convened a hearing on 19 November 2020 Chaired by Senator Ron Johnson (R-WI) to examine “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution.” This hearing was not televised nationally and was sparsely attended, even by its own […]
Washington Beyond the Headlines: Alcohol Consumption Guidelines Lowered (Again)
By Andy Blom, TES Washington Editor More elections! There are still undecided seats in Congress and the runoff for control of the Senate in Georgia, which is recently looking more purple than red — something hard to imagine a decade ago. The role of outside money probably has something to do with it: by […]
The Global Democratization of Finance
By Bradley Hook & Adam Traidman Technological advances, a changing global paradigm, and the COVID-19 pandemic have combined in unprecedented ways to alter the way we use, move, and invest money. Whether the focus is on emerging economies and the unbanked or new ways to raise investments from a global pool of potential […]
Refuting Dr. Ashish Jha’s “Dangerous” and Deceptive Testimony
By Erik Sass, TES Editor-in-Chief There comes a time when a public figure’s statements are so wrong, so dangerous, and so grossly offensive that they must be rebutted and debunked one by one. This is the case with the Senate testimony and subsequent New York Times op-ed and media appearances by Dr. Ashish Jha, […]
Blind gallery owner: Ideas are more important than what you see!
By Dr. Rainer Zitelmann The coronavirus crisis has left many people facing massive problems, fears and financial difficulties. In challenging times, it makes a great deal of sense to focus on people who have defied the odds and taken their lives into their own hands. People who, despite severe disabilities, do not approach life […]
EU is right to scrutinize Chinese investment
“Not all foreign investment is welcome in Europe” By Julia Anderson, courtesy of the Bruegel Institute Imagine that the Tour de France allowed non-French competitors, and only non-French competitors, to use performance-enhancing drugs. Now imagine these rules were changed to ban the use of drugs for all competitors. It would surely make for a […]
The International Criminal Court Believes that Human Rights Are Being Violated in Venezuela
By Federico N. Fernández, Fundacion Bases/AEC Important progress has been made in order to bring Venezuelan dictator Nicolás Maduro to court for crimes against humanity. On November 5, Fatou Bensouda, the prosecutor of the International Criminal Court (ICC), stated that there is “a reasonable basis to believe that crimes within the jurisdiction of the […]